 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Beyond Air: New data supports development of nNOS inhibitors for ASD treatment

New data demonstrates a therapeutic effect for at least 10 days after a single subcutaneously (SC) injection of an extended-release selective neuronal nitric oxide synthase (nNOS) inhibitor The...

Beyond Air  Announces Publication of Positive New Preclinical Data for the Treatment of Autism Spectrum Disorder

This is a signal that XAIR's price trend could be reversing, and it may be an opportunity to buy the stock or explore call options...

Beyond Air (XAIR, $3.02) Stochastic Oscillator left the oversold zone on September 15, 2023

This indicator may be signaling that XAIR's price has further to drop, since it moved below its price 14 days ago. Traders may consider selling the stock, shorting the stock, or exploring put options...

Beyond Air (XAIR, $3.14) entered Downtrend as Momentum indicator drops below 0 level on Sep 14, 2023

This is a signal that XAIR's price trend could be reversing, and it may be an opportunity to sell the stock or take a defensive position...

Beyond Air (XAIR, $3.11) Stochastic Oscillator left the overbought zone on September 13, 2023

Cochlear (OTCMKTS:CHEOF  Get Free Report) and Beyond Air (NASDAQ:XAIR  Get Free Report) are both medical companies, but which is the superior business? We will compare the two companies...

Head-To-Head Contrast: Cochlear (OTCMKTS:CHEOF) vs. Beyond Air (NASDAQ:XAIR)

Beyond Air and Getz Healthcare partner to market LungFit PH in Asia-Pacific

Partnership provides access to hospitals in key Asia-Pacific countries Getz Healthcare will make a payment to Beyond Air upon receipt of CE Mark Beyond Air will receive royalty payments...

Beyond Air  and Getz Healthcare Enter Strategic Collaboration to Commercialize LungFit PH in Asia-Pacific Region

GARDEN CITY, N.Y., Sept. 06, 2023 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) ( Beyond Air or the Company ) a commercial stage medical device and biopharmaceutical company focused on...

Beyond Air  To Participate in the 2023 Cantor Global Healthcare Conference

Beyond Air (XAIR, $3.13) Stochastic Oscillator left the overbought zone on September 05, 2023

Beyond Air, Inc. is a commercial stage medical device and biopharmaceutical company, which engages in developing a platform for nitric oxide generators and delivery systems. It operates through the Beyond Air and Beyond Cancer segments. The company was founded on April 28, 2015 and is headquartered in Garden City, NY.

Watchers	4,099
52-Wk Low	$2.55
52-Wk High	$8.46

Market Cap	$84.35M
Volume (M)	362,010.00
52-Wk High	$8.46
52-Wk Low	$2.55

XAIR Beyond Air Inc

About

Feed

News

Sentiment

Earnings

Fundamentals